• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. BlueTheory Announces Rebrand to BTC Network New Business Model to Streamline All Clinical Trial Needs

    BlueTheory Announces Rebrand to BTC Network New Business Model to Streamline All Clinical Trial Needs

  2. Green Circle Health and Inclinical Partner to Expand the Role of Patient-Reported Data in Clinical Trials

    Green Circle Health and Inclinical Partner to Expand the Role of Patient-Reported Data in Clinical Trials

  3. University of Southampton Leverages Medidata Clinical Cloud to Bridge Innovation Gap Between Academia and UK Drug Development Industry

    University of Southampton Leverages Medidata Clinical Cloud to Bridge Innovation Gap Between Academia and UK Drug Development Industry

  4. Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise

    Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise

  5. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  6. Indegene and TranScrip Launch IntraScience - an Innovative Regulatory, Safety and Medical Services Solution for Global Bio-Pharmaceutical Companies

    Indegene and TranScrip Launch IntraScience - an Innovative Regulatory, Safety and Medical Services Solution for Global Bio-Pharmaceutical Companies

  7. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  8. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.